Market Research Logo

Global Diabetic Neuropathy Drugs Market 2019-2023

Global Diabetic Neuropathy Drugs Market 2019-2023

About this market

The rising awareness about diabetic neuropathy is one of the prominent factors likely to contribute to the diabetic neuropathy drugs market growth in the forthcoming years. Several awareness programs are being launched among the consumers with an aim to educate and train diabetes educators in the emerging and advanced economies. Different campaigns are encouraging people to take an online test for knowing about the risk factors associated with prediabetes, in turn, driving the diabetic neuropathy drugs market growth during the forecast period. Technavio’s analysts have predicted that the diabetic neuropathy drugs market will register a CAGR of about 6% by 2023.

Market Overview

New drug approvals and strong drug pipeline

One of the growth drivers of the global diabetic neuropathy drugs market is new drug approvals and strong drug pipeline. With the rising prevalence of diabetic neuropathy, several market players are focusing on the development of disease-modifying drugs to treat the disease.

Side-effects of major drugs

One of the challenges in the growth of the global diabetic neuropathy drugs market is the side-effects of major drugs. Side-effects associated with approved drugs such as pregabalin (LYRICA) and gabapentin (NEURONTIN) can lead to low patient compliance, thereby hindering the growth of the market.

For the detailed list of factors that will drive and challenge the growth of the diabetic neuropathy drugs market during 019-2023, view our report.

Competitive Landscape

The market appears to be moderately fragmented with the presence of several market players. Vendors in the market are focusing on the development of novel biologics to treat diabetic neuropathy. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.


Press Release

Technavio Announces the Publication of its Research Report – Global Diabetic Neuropathy Drugs Market 2019-2023

Technavio recognizes the following companies as the key players in the global diabetic neuropathy drugs market: DAIICHI SANKYO COMPANY, LIMITED, Eli Lilly and Company, Johnson & Johnson Services, Inc., Novartis AG, and Pfizer Inc.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the development of novel biologics to treat diabetic neuropathy.”

According to the report, one of the major drivers for this market is the new drug approvals and strong drug pipeline.

Further, the report states that one of the major factors hindering the growth of this market is the side-effects of major drugs.

Companies Mentioned

DAIICHI SANKYO COMPANY, LIMITED
Eli Lilly and Company
Johnson & Johnson Services, Inc.
Novartis AG
Pfizer Inc.

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Market segmentation by mechanism of action
    • Table Mechanism of action - Market share 2018-2023 (%)
    • Comparison by mechanism of action
      • Table Comparison by mechanism of action
    • Calcium channel alpha-2-delta ligand - Market size and forecast 2018-2023
      • Table Calcium channel alpha-2-delta ligand - Market size and forecast 2018-2023 ($ millions)
      • Table Calcium channel alpha-2-delta ligand - Year-over-year growth 2019-2023 (%)
    • SNRIs and TCAs - Market size and forecast 2018-2023
      • Table SNRIs and TCAs - Market size and forecast 2018-2023 ($ millions)
      • Table SNRIs and TCAs - Year-over-year growth 2019-2023 (%)
    • Others - Market size and forecast 2018-2023
      • Table Others - Market size and forecast 2018-2023 ($ millions)
      • Table Others - Year-over-year growth 2019-2023 (%)
    • Market opportunity by mechanism of action
      • Table Market opportunity by mechanism of action
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Pipeline drugs for diabetic neuropathy
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
    • Table Biologics under development
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • DAIICHI SANKYO COMPANY, LIMITED
      • Table DAIICHI SANKYO COMPANY, LIMITED - Vendor overview
      • Table DAIICHI SANKYO COMPANY, LIMITED - Business segments
      • Table DAIICHI SANKYO COMPANY, LIMITED - Organizational developments
      • Table DAIICHI SANKYO COMPANY, LIMITED - Geographic focus
      • Table DAIICHI SANKYO COMPANY, LIMITED - Segment focus
      • Table DAIICHI SANKYO COMPANY, LIMITED - Key offerings
    • Eli Lilly and Company
      • Table Eli Lilly and Company - Vendor overview
      • Table Eli Lilly and Company - Business segments
      • Table Eli Lilly and Company - Organizational developments
      • Table Eli Lilly and Company - Geographic focus
      • Table Eli Lilly and Company - Segment focus
      • Table Eli Lilly and Company - Key offerings
    • Johnson & Johnson Services, Inc.
      • Table Johnson & Johnson Services, Inc. - Vendor overview
      • Table Johnson & Johnson Services, Inc. - Business segments
      • Table Johnson & Johnson Services, Inc. - Organizational developments
      • Table Johnson & Johnson Services, Inc. - Geographic focus
      • Table Johnson & Johnson Services, Inc. - Segment focus
      • Table Johnson & Johnson Services, Inc. - Key offerings
    • Novartis AG
      • Table Novartis AG - Vendor overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Organizational developments
      • Table Novartis AG - Geographic focus
      • Table Novartis AG - Segment focus
      • Table Novartis AG - Key offerings
    • Pfizer Inc.
      • Table Pfizer Inc. - Vendor overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Organizational developments
      • Table Pfizer Inc. - Geographic focus
      • Table Pfizer Inc. - Segment focus
      • Table Pfizer Inc. - Key offerings
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report